This article has been updated with comments from Qiagen's earnings call on Friday.

NEW YORK (GenomeWeb) – Qiagen reported on Thursday that its second quarter revenues grew 4 percent year over year or 6 percent at constant exchange rates, prompting the firm to slightly raise its full-year adjusted revenue guidance.

For the three months ended June 30, the company reported revenues of $349.0 million, up from $334.4 million a year ago, and beating the average Wall Street estimate of $346.6 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.